Systemic Sclerosis in Zimbabwe: Autoantibody Biomarkers, Clinical, and Laboratory Correlates.
Zimbabwe
autoantibodies
clinical
cutaneous
laboratory
respiratory
systemic sclerosis
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
12
03
2021
accepted:
30
09
2021
entrez:
3
12
2021
pubmed:
4
12
2021
medline:
8
1
2022
Statut:
epublish
Résumé
Systemic sclerosis (SScl) is an autoimmune disease whose prevalence is rarely reported in Africa. Autoantibodies are the biomarkers of the condition, precede overt disease and determine disease phenotypes. SSc specific autoantibodies also vary between racial groupings. Objective: To investigate the clinical and laboratory characteristics of Zimbabwean patients who were reactive SSc specific autoantibodies. 240 patients, 173 of them female with SSc specific autoantibodies were included. Autoantibodies were detected by indirect immunofluorescence microscopy and immunoblotting using a panel of 13 SScl (Euroimmun Ag., Germany). Demographic, clinical and laboratory parameters relevant to the monitoring of SScl were captured. These included pulmonary function tests, hematology, clinical chemistry, serology and thyroid function tests. Allergy skin prick tests (SPT) to inhalant and food allergen sources were conducted when indicated. All the 240 patients (median age was 36 years) expressed SSc specific autoantibodies. 86% were Black, 11% White and 3% Asian and a fifth (20%) were younger than 16 years. Eleven (4.6%) fulfilled the ACR/EULAR classification of SSc. Clinically they had limited cutaneous (n=6), diffuse cutaneous (n=3) and SScl/inflammatory myopathy overlap (n=2). The most frequently detected antibodies anti-RNA polymerase III (RNAP) 55%, anti-Th/To (28%) anti-RNAP 11 (22%), anti-CENPB (18%) and anti-Scl-70/ATA (13%). Racial variations in the expression of these antibodies were apparent between Black, White and Asian patients. The majority (95%), who did not fulfil the ARA/EULAR criteria were symptomatic. Raynaud's Phenomenon was documented in 24%. Respiratory symptoms included coughing, dyspnea and wheezing. There was a restrictive ventilatory defect with increased FEV1/FVC ratio. Pruritus, urticaria and skin depigmentation were the main cutaneous features while constipation, bloating, Gastroesophageal reflux disease (GERD) and abdominal pain dominated GI symptoms. Mean blood pressure readings while normal varied with biomarkers. Haematology and biochemistry parameters were within normal reference ranges. The expression of SSc specific autoantibodies is common and associated with known SSc symptoms. The types and frequency of autoantibodies varied with racial groupings. A fifth of the patients were children below the age of 16 years.
Identifiants
pubmed: 34858387
doi: 10.3389/fimmu.2021.679531
pmc: PMC8631108
doi:
Substances chimiques
Autoantibodies
0
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
679531Subventions
Organisme : Department of Health
ID : 16/136/33
Pays : United Kingdom
Informations de copyright
Copyright © 2021 Sibanda, Dube, Chakawa, Mduluza and Mutapi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Medicine (Baltimore). 2013 Jul;92(4):191-205
pubmed: 23793108
Arthritis Res Ther. 2009;11(1):R22
pubmed: 19220911
J Rheumatol. 2006 Feb;33(2):263-8
pubmed: 16465656
Arch Intern Med. 1968 Jul;122(1):39-42
pubmed: 5659375
Curr Opin Rheumatol. 2012 Mar;24(2):165-70
pubmed: 22269658
Autoimmun Rev. 2013 Jan;12(3):374-9
pubmed: 22743031
PLoS One. 2019 Mar 26;14(3):e0214202
pubmed: 30913258
Front Immunol. 2015 Apr 15;6:167
pubmed: 25926833
Arch Med Sci. 2015 Dec 10;11(6):1255-60
pubmed: 26788088
Arthritis Rheum. 2003 Jan;48(1):203-9
pubmed: 12528120
Arthritis Rheum. 2003 Aug;48(8):2246-55
pubmed: 12905479
Rheumatology (Oxford). 2004 May;43(5):596-602
pubmed: 14872101
Ann Rheum Dis. 2007 Apr;66(4):551-3
pubmed: 16984943
Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):118-21
pubmed: 23910615
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14
pubmed: 22556030
J Int Med Res. 2008 Jan-Feb;36(1):152-6
pubmed: 18304414
Curr Rheumatol Rep. 2017 Sep 18;19(10):65
pubmed: 28921059
Arthritis Rheum. 2006 Jul;54(7):2243-9
pubmed: 16802363
J Rheumatol. 2003 Sep;30(9):1994-6
pubmed: 12966604
An Bras Dermatol. 2011 Nov-Dec;86(6):1075-81
pubmed: 22281893
Arthritis Rheum. 2012 Sep;64(9):2986-94
pubmed: 22576620
Arthritis Res Ther. 2019 Dec 2;21(1):262
pubmed: 31791379
J Rheumatol. 2001 Jul;28(7):1573-6
pubmed: 11469464
Rheumatology (Sunnyvale). 2018;8(1):
pubmed: 30057856
N Engl J Med. 2009 May 7;360(19):1989-2003
pubmed: 19420368
Ann Rheum Dis. 2013 Nov;72(11):1747-55
pubmed: 24092682
Clin Rheumatol. 2006 Nov;25(6):831-4
pubmed: 16435160